This announcement is a separate document:
大洋生物：关于回购公司股份比例达到总股本3%暨回购进展公告
Zhejiang Dayang Biotech Group: Announcement on the progress of share repurchase reaching 3% of the total share capital.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated